Additional H1N1 Vaccine Recalled

The Centers for Disease Control and Prevention

(Cindy Hadish/The Gazette)

Tools

By Becky Ogann

The Centers for Disease Control and Prevention (CDC) has announced a non-safety related voluntary recall of certain lots of H1N1 influenza intranasal vaccine.

The vaccine, manufactured by MedImmune, successfully passed pre-release testing for purity, potency and safety. However, because its potency is now or might soon be below the specified lower limit, MedImmune will send providers directions for returning any unused vaccine from these lots.

According to the Iowa Department of Public Health (IDPH), Iowa was allocated approximately 46,900 doses of the affected nasal mist vaccine.

“The majority of this vaccine was administered in October, when its potency was not an issue,” said IDPH Immunization and Tuberculosis Bureau Chief Don Callaghan. “Because the vaccine was administered long before this recall, there are no concerns about its effectiveness.” Individuals who received the affected intranasal vaccine do not need to be re-vaccinated.

Conversation Guidelines

Be Kind

Don't use abusive, offensive, threatening, racist, vulgar or sexually-oriented language.
Don't attack someone personally. Keep it civil and be responsible.

Share Knowledge

Be truthful. Share what you know and what you are passionate about.
What more do you want to learn? Keep it simple.

Stay focused

Promote lively and healthy debate. Stay on topic. Ask questions and give feedback on the story's topic.

Report Trouble

Help us maintain a quality comment section by reporting comments that are offensive. If you see a comment that is offensive, or you feel violates our guidelines, simply click on the "x" to the far right of the comment to report it.


read the full guidelines here »

Commenting will be disabled on stories dealing with the following subject matter: Violent crime, sexual abuse, Amber Alerts, Operation Quickfinds and suicides.

More Good Stuff

What's On KCRG